Can the duration of obesity, diet, and physical activity be determinants in metabolic healthy obesity?
Main Article Content
Keywords
Diet, Physicial Activity, Healthy obesity, Obese subgoups, Unhealthy obesity
Abstract
Objective: A subgroup is defined as metabolic healthy obese, resistant to the development of complications caused by obesity. This study aims to evaluate the difference between obese subgroups in terms of diet, physical activity, and time spent obese.
Methods: 401 individuals between the ages of 18-65 with a body mass index greater than 30 kg/m2 participated in the study. A questionnaire form was applied in which the general characteristics of the individuals were questioned, anthropometric measurements were made, and biochemical blood parameters were taken. Food consumption and physical activity records were taken. According to the metabolic syndrome diagnostic criteria, ATP III, individuals are classified as metabolically healthy or metabolically unhealthy.
Results: At the end of the study, 60% of women (n=147) and 69% of men (n=109) were found to be metabolically unhealthy obese (p0.05). It was observed that the amount of energy, total fat, saturated fat, and carbohydrates taken with the daily diet are higher in those with unhealthy obesity than in the healthy obese (p0.05). The risk of metabolic unhealthy obesity was found to be 2.2 times higher in individuals with a body mass index over 30 kg/m2 for more than 10 years. After the age of 52, the risk of being obese with metabolic unhealthy is 2.5 times higher.
Conclusion: It is thought that lifestyle may be a distinguishing factor in the group of obesity resistant to metabolic risk factors. Clarification of the possible effects of nutrition in metabolically healthy obese will be important in the treatment of obesity.
References
2. World Health Organization. (2021). “Obesity and Overweight”. http://www.who.int/en/news-room/factsheets/detail/obesity-and-overweight. Accessed 2022.
3. Sağlık Bakanlığı. Türkiye Beslenme ve Sağlık Araştırması (TBSA) 2017. 2019. Accessed : https://hsgm.saglik.gov.tr/depo/birimler/saglikli-beslenme-hareketli-hayat-db/Yayinlar/kitaplar/TBSA_RAPOR_KITAP_20.08.pdf .
4. Sims EA. Are there persons who are obese, but metabolically healthy? Metabolism-Clinical and Experimental 2001; 50(12): 1499-1504.
5. Blüher M. The distinction of metabolically ‘healthy’from ‘unhealthy’obese individuals. Current Opinion in Lipidology 2010;21(1): 38-43.
6. Roberson L, Aneni E, Maziak W, et al. Beyond BMI: The “Metabolically healthy obese” phenotype & its association with clinical/subclinical cardiovascular disease and all-cause mortality—A systematic review. BMC Public Health 2014; 14(1): 1–12.
7. Wildman RP, Munter P, Reynolds K, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalance and correlates of 2 phenotypes among US population (NHANES 1999-2004). Archives of İnternal Medicine 2008; 168(15), 1617-1624.
8. Jana V, Marja N, Sandra NS, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocrine Disorders 2014;14(1): 1-13.
9. Seo Y, Lee S, Ahn JS, et al. Association of metabolically healthy obesity and future depression: using national health insurance system data in Korea from 2009–2017. International Journal of Environmental Research and Public Health 2021; 18(1): 63.
10. Hoyas I, Leon-Sanz M. Nutritional challenges in metabolic syndrome. Journal of Clinical Medicine 2019; 8(9): 1301.
11. Slagter SN, Corpelejin E, Van Der Klauw MM, et al. Dietary patterns and physical activity in the metabolically (un) healthy obese: the Dutch Lifelines cohort study. Nutrition Journal 2018;17(1): 1-14.
12. Expert Panel on Detection, Evaluation, et al. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Jama 2001;285(19):2486–2497.
13. Rakicioglu N, Acar Tek N, Ayaz A, et al. Yemek ve besin fotoğraf kataloğu. (3. Baskı). Hatiboğlu Yayınevi. 2012;3:1-131.
14. Sistemleri, B.B., Ebispro for Windows. Stuttgart, Germany, 2004.
15. Saglam M, Arikan H, Savici S, et al. International physical activity questionnaire: reliability and validity of the Turkish version. Perceptual and Motor Skills 2010; 111(1): 278-284.
16. Ramachandran A, Snehalatha C, Satyavani K, et al. Metabolic syndrome in urban Asian Indian adults—a population study using modified ATP III criteria. Diabetes Research and Clinical Practice 2003; 60(3): 199-204
17. Van JV, Nuotio M, Slagter S, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: A collaborative analysis of ten large cohort studies. BMC Endocrine Disorders 2014; 14 (1): 9–22.
18. Iacobini C, Pugliese G, Fantauzzi CB, et al. Metabolically healthy versus metabolically unhealthy obesity. Metabolism 2019; 92: 51-60.
19. Stefan N, Häring HU and Matthias BS. Metabolically healthy obesity: the low-hanging fruit in obesity treatment?. The Lancet Diabetes & Endocrinology 2018; 6(3): 249-258.
20. Kim D, Ahn BI. Eating out and consumers’ health: evidence on obesity and balanced nutrition intakes. International Journal of Environmental Research and Public Health 2020; 17(2): 586.
21. Magkos F. Metabolically healthy obesity: what's in a name?. The American Journal of Clinical Nutrition 2019;110 (3): 533-539.
22. Micha R, Peñalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. Jama 2017; 317(9):12–24.
23. Dehghan M, Mente A, Zhang X, et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study. The Lancet 2017; 390 (10107): 2050–2062.
24. Teng KT, Chang CY, Chang LF, Nesaretnam K, Modulation of obesity-induced inflammation by dietary fats:mechanisms and clinical evidence. Nutrition Journal 2014; 13(1): 12.
25. Blüher M. Metabolically healthy obesity. Endocrine Reviews 2020; 41(3): bnaa004.
26. Jennings CL, Lambert EV, Collins M, et al. Determinants of insulin‐resistant phenotypes in normal‐weight and obese Black African women. Obesity 2008; 16(7): 1602-1609.
27. Yu R, Yau F, Ho SC, et al. Associations of cardiorespiratory fitness, physical activity, and obesity with metabolic syndrome in Hong Kong Chinese midlife women. BMC Public Health 2013;13(1): 1-10.
28. Hwang YC, Hayashi T, Fujimoto WY, et al. Visceral abdominal fat accumulation predicts the conversion of metabolically healthy obese subjects to an unhealthy phenotype. International Journal of Obesity 2015; 39(9): 1365-1370.
29. Soriguer F, Gutierrez-Repiso C, Rubio-Martin E, et al. Metabolically healthy but obese, a matter of time? Findings from the prospective Pizarra study. The Journal of Clinical Endocrinology & Metabolism 2013; 98(6): 2318-2325.
Article Sidebar
Article Details
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
